** Shares of healthcare company Haemonetics Corp HAE.N up
1.6% at $90.09
** Co raises FY24 adj. profit forecast to $3.60-$3.90 per
share from its prior guidance of $3.45-$3.75
** Reports Q1 revenue of $311 mln, up 19% from a year
earlier and above analysts' expectations of $292.7 mln -
Refinitiv
** Posts Q1 profit of $1.05/shr, topping estimates of 73
cents/shr
** Five of eight brokerages rate the stock "buy" or higher
and three "hold"; their median PT is $105.29
** HAE up 14.77% YTD
(Reporting by Anandita Mehrotra in Bengaluru)
((Anandita.Mehrotra@thomsonreuters.com))